Related Experiment Video
Updated: Jun 27, 2026

10:41
Wild-type Blocking PCR Combined with Direct Sequencing as a Highly Sensitive Method for Detection of Low-Frequency Somatic Mutations
Published on: March 29, 2017
Quality of diagnostic mutation analyses for phenylketonuria
J Zschocke1, C Aulehla-Scholz, S Patton
1Institute of Human Genetics, Heidelberg University, Heidelberg, Germany. humgen@i-med.ac.at
Journal of Inherited Metabolic Disease
|November 19, 2008
Summary
DNA mutation analysis for phenylketonuria (PKU) can be inaccurate. External quality assessments reveal errors in mutation detection and genotype interpretation, impacting patient diagnosis and care.
Area of Science:
- Medical Genetics
- Molecular Diagnostics
Background:
- DNA sequencing is crucial for diagnosing genetic disorders like phenylketonuria (PKU).
- However, the accuracy of reported DNA analysis results is often overlooked.
- External Quality Assessment (EQA) schemes are vital for evaluating laboratory performance.
Purpose of the Study:
- To assess the accuracy of mutation analysis in phenylketonuria (PKU) laboratories.
- To identify common errors in mutation detection and genotype interpretation.
- To highlight the importance of quality control in genetic testing.
Main Methods:
- An External Quality Assessment (EQA) scheme was conducted over four years.
- Participating laboratories received DNA samples with known genotypes for PKU mutation analysis.
- Methodologies included comprehensive mutation detection, such as PAH gene exon sequencing.
Main Results:
- Several laboratories failed to detect mutations due to methodological issues.
- Laboratories using comprehensive methods missed mutations, with nearly 8% incorrect genotypes reported in 2007.
- Significant deficiencies were observed in interpreting genotype data, including missing or incorrect phenotype information.
Conclusions:
- Mutation analysis in genetic diagnostics is susceptible to errors.
- Accurate interpretation of genotype data, considering clinical and biochemical findings, is essential.
- EQA schemes are critical for ensuring the reliability of genetic testing services.
Related Concept Videos
Inborn Errors of Metabolism
Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
Mutations
Overview

